General Information of the Compound
| Compound ID |
CP0294411
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
9-fluoro-5H-quinolino[8,7-c][1,2]benzothiazine 6,6-dioxide
Show/Hide
|
||||||||||||||||||
| Synonyms |
9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide
BDBM50372499
CHEMBL270799
KNMYXLXOQAHLHK-UHFFFAOYSA-N
NCGC00163040-01
SCHEMBL11972977
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C15H9FN2O2S
|
||||||||||||||||||
| Molecular Weight |
300.314
|
||||||||||||||||||
| Canonical SMILES |
Fc1ccc2c(c1)-c1ccc3cccnc3c1NS2(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C15H9FN2O2S/c16-10-4-6-13-12(8-10)11-5-3-9-2-1-7-17-14(9)15(11)18-21(13,19)20/h1-8,18H
Show/Hide
|
||||||||||||||||||
| InChIKey |
KNMYXLXOQAHLHK-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT05222, NF-kappa-B inhibitor alpha
Protein ID: PT06104, Solute carrier family 40 member 1
Clinical Information about the Compound
Drug 1 ( 9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide )
| Drug Name | 9-fluoro-5H-6-thia-4,5-diaza-chrysene 6,6-dioxide | ||
|---|---|---|---|